Thomas M. Vescio

10 papers receiving 717 citations

Thomas M. Vescio's Hit Papers

Teprotumumab for the Treatment of Active Thyroid Eye Disease 2020 · 549 citations
5490+2+4Years since publication100200300400500

Peers

Thomas M. Vescio
Comparison fields: 5 of 54
  • Pathology and Forensic Medicine 438
  • Endocrinology, Diabetes and Metabolism 175
  • Clinical Biochemistry 67
  • Ophthalmology 78
  • Infectious Diseases 122
Replace Jelena Juri with:
Jelena Juri Croatia
Süleyman Nahit Şendur Türkiye
Chris Press United States
K. S. Fong Singapore
Helena Proença Portugal
Giulio Frontino Italy
Nadim S. Azar United States
Laura Lavilla Spain
S. Baillot-Rudoni France
Cuma Mertoğlu Türkiye
Thomas M. Vescio relative to Jelena Juri Croatia Jelena Juri's profile →
Citations per field
00.5×10×20×33.5×
Jelena Juri · 1×
Citations per year

Countries citing papers authored by Thomas M. Vescio

Since Specialization
Citations

This map shows the geographic impact of Thomas M. Vescio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas M. Vescio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas M. Vescio more than expected).

Fields of papers citing papers by Thomas M. Vescio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas M. Vescio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas M. Vescio. The network helps show where Thomas M. Vescio may publish in the future.

Co-authors

The 25 scholars most cited alongside Thomas M. Vescio, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas M. Vescio Line = papers co-authored together Thomas M. Vescio links everyone, so they are left out of the graph.

All Works

10 of 10 papers shown
#Work
1
Teprotumumab for the Treatment of Active Thyroid Eye Disease
Hit paper breakdown →
2020549
2 200698
3 200331
4 200624
5 201916
6 202014
7 20206
8
Teprotumumab use in a real-world setting: Expanded access program findings
20212
9 20031
10 20031

About Thomas M. Vescio

Thomas M. Vescio is a scholar working on Clinical Biochemistry, Infectious Diseases, Pathology and Forensic Medicine, Ophthalmology and Endocrinology, Diabetes and Metabolism, having authored 10 papers that have together received 742 indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (5 papers), Bacterial Identification and Susceptibility Testing (4 papers), Ophthalmology and Eye Disorders (3 papers), Metabolism and Genetic Disorders (2 papers), Bacterial biofilms and quorum sensing (2 papers), Thyroid Disorders and Treatments (1 paper), Retinal and Optic Conditions (1 paper) and Drug-Induced Ocular Toxicity (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (438 citations), Endocrinology, Diabetes and Metabolism (175 citations), Clinical Biochemistry (67 citations), Ophthalmology (78 citations) and Infectious Diseases (122 citations). Thomas M. Vescio has collaborated with scholars based in United States, France and Canada. Frequent co-authors include Kamaljit S Singh, Lynne S. Kaminer, Richard B. Thomson, Adrienne G. Fisher, Patrick J. Gavin, Gary A. Noskin, Lance R. Peterson, Nicola Longo, Shawn E. McCandless and Uta Lichter‐Konecki. Their work appears in journals such as Molecular Genetics and Metabolism, Infection Control and Hospital Epidemiology, Investigative Ophthalmology & Visual Science, Journal of Clinical Microbiology and New England Journal of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact